Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miwa Takai-Imamura"'
Autor:
Iwao Seki, Miwa Takai-Imamura, Tomomi Kohara-Tanaka, Satoshi Shirae, Minoru Sasano, Hiroaki Matsuno, Hiroyuki Aono
Publikováno v:
Mediators of Inflammation, Vol 2019 (2019)
In the present study, we investigated the effects and mechanisms of action of a combined treatment with etanercept, a soluble tumor necrosis factor receptor (p75) Fc fusion protein, and tacrolimus, a calcineurin inhibitor on the progression of arthri
Externí odkaz:
https://doaj.org/article/9a36ee8a65d843469aff6adaeb06fa00
Autor:
Ayano Yahagi, Taro Saika, Hiroyasu Hirano, Miwa Takai-Imamura, Fumio Tsuji, Hiroyuki Aono, Masanori Iseki, Yoshitaka Morita, Hideya Igarashi, Yukihiko Saeki, Katsuhiko Ishihara
Publikováno v:
RMD Open; 6/21/2019, Vol. 5, p1-11, 11p
Autor:
Kusuki Nishioka, Hiroyuki Aono, Keiko Funahashi, Miwa Takai-Imamura, Osamu Katsuta, Noriko Odani-Kawabata, Tsukasa Matsubara, Minoru Sasano, Hiroshi Nakamura
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 11, Iss 1, p 221 (2010)
BMC Musculoskeletal Disorders, Vol 11, Iss 1, p 221 (2010)
Background The anti-human Fas/APO-1/CD95 (Fas) mouse/human chimeric monoclonal IgM antibody ARG098 (ARG098) targets the human Fas molecule. The cytotoxic effects of ARG098 on cells isolated from RA patients, on normal cells in vitro, and on RA synovi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3183f8d20961f78ce788a9c21d3103
http://europepmc.org/articles/PMC3161399
http://europepmc.org/articles/PMC3161399